Literature DB >> 33302541

Comprehensive Review on Alzheimer's Disease: Causes and Treatment.

Zeinab Breijyeh1, Rafik Karaman1.   

Abstract

Alzheimer's disease (AD) is a disorder that causes degeneration of the cells in the brain and it is the main cause of dementia, which is characterized by a decline in thinking and independence in personal daily activities. AD is considered a multifactorial disease: two main hypotheses were proposed as a cause for AD, cholinergic and amyloid hypotheses. Additionally, several risk factors such as increasing age, genetic factors, head injuries, vascular diseases, infections, and environmental factors play a role in the disease. Currently, there are only two classes of approved drugs to treat AD, including inhibitors to cholinesterase enzyme and antagonists to N-methyl d-aspartate (NMDA), which are effective only in treating the symptoms of AD, but do not cure or prevent the disease. Nowadays, the research is focusing on understanding AD pathology by targeting several mechanisms, such as abnormal tau protein metabolism, β-amyloid, inflammatory response, and cholinergic and free radical damage, aiming to develop successful treatments that are capable of stopping or modifying the course of AD. This review discusses currently available drugs and future theories for the development of new therapies for AD, such as disease-modifying therapeutics (DMT), chaperones, and natural compounds.

Entities:  

Keywords:  Alzheimer’s disease; chaperons; disease-modifying therapy; heat shock proteins; neurodegeneration; risk factors; tau protein; β-amyloid peptide

Mesh:

Substances:

Year:  2020        PMID: 33302541      PMCID: PMC7764106          DOI: 10.3390/molecules25245789

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  141 in total

Review 1.  Metals and Alzheimer's disease.

Authors:  Paul A Adlard; Ashley I Bush
Journal:  J Alzheimers Dis       Date:  2006-11       Impact factor: 4.472

Review 2.  Alzheimer's disease: clinical features, pathogenesis, and treatment.

Authors:  K L Rathmann; C S Conner
Journal:  Drug Intell Clin Pharm       Date:  1984-09

Review 3.  Dementia of the Alzheimer type.

Authors:  R D Terry; P Davies
Journal:  Annu Rev Neurosci       Date:  1980       Impact factor: 12.449

Review 4.  Ozone Atmospheric Pollution and Alzheimer's Disease: From Epidemiological Facts to Molecular Mechanisms.

Authors:  Marine L Croze; Luc Zimmer
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 5.  The role of apolipoprotein E in Alzheimer's disease.

Authors:  Jungsu Kim; Jacob M Basak; David M Holtzman
Journal:  Neuron       Date:  2009-08-13       Impact factor: 17.173

6.  Obesity as a risk factor for Alzheimer's disease: weighing the evidence.

Authors:  S Alford; D Patel; N Perakakis; C S Mantzoros
Journal:  Obes Rev       Date:  2017-10-10       Impact factor: 9.213

Review 7.  Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis.

Authors:  Cláudia Y Santos; Peter J Snyder; Wen-Chih Wu; Mia Zhang; Ana Echeverria; Jessica Alber
Journal:  Alzheimers Dement (Amst)       Date:  2017-02-09

8.  Pharmacological aspects of galantamine for the treatment of Alzheimer's disease.

Authors:  Jae Kwang Kim; Sang Un Park
Journal:  EXCLI J       Date:  2017-01-10       Impact factor: 4.068

9.  Full recovery of the Alzheimer's disease phenotype by gain of function of vacuolar protein sorting 35.

Authors:  Jian-Guo Li; Jin Chiu; Domenico Praticò
Journal:  Mol Psychiatry       Date:  2019-02-07       Impact factor: 13.437

Review 10.  Clinical trials of new drugs for Alzheimer disease.

Authors:  Li-Kai Huang; Shu-Ping Chao; Chaur-Jong Hu
Journal:  J Biomed Sci       Date:  2020-01-06       Impact factor: 8.410

View more
  107 in total

Review 1.  The protective role of exercise against age-related neurodegeneration.

Authors:  Alyson Sujkowski; Luke Hong; R J Wessells; Sokol V Todi
Journal:  Ageing Res Rev       Date:  2021-12-17       Impact factor: 10.895

2.  Temporal Subtyping of Alzheimer's Disease Using Medical Conditions Preceding Alzheimer's Disease Onset in Electronic Health Records.

Authors:  Zhe He; Shubo Tian; Arslan Erdengasileng; Neil Charness; Jiang Bian
Journal:  AMIA Annu Symp Proc       Date:  2022-05-23

Review 3.  Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer's Disease: A comprehensive review.

Authors:  Hannah W Haddad; Garett W Malone; Nicholas J Comardelle; Arielle E Degueure; Salomon Poliwoda; Rachel J Kaye; Kevin S Murnane; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-07-28

4.  Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer's Disease: A Comprehensive Review.

Authors:  Hannah W Haddad; Garett W Malone; Nicholas J Comardelle; Arielle E Degueure; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-01-30

5.  Classifying mild cognitive impairment and Alzheimer's disease by constructing a 14-gene diagnostic model.

Authors:  Jing Han; Gang-Hua Feng; Hua-Wu Liu; Ji-Ping Yi; Ji-Bao Wu; Xiao-Xi Yao
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

6.  Neuroprotective Effects of Oligosaccharides in Rehmanniae Radix on Transgenic Caenorhabditis elegans Models for Alzheimer's Disease.

Authors:  Nianxin Kang; Yage Luan; Yu Jiang; Wenhao Cheng; Yongjian Liu; Zhijun Su; Yonggang Liu; Peng Tan
Journal:  Front Pharmacol       Date:  2022-06-17       Impact factor: 5.988

Review 7.  Research Progress of Pyroptosis in Alzheimer's Disease.

Authors:  Weiyue Xue; Di Cui; Ye Qiu
Journal:  Front Mol Neurosci       Date:  2022-06-16       Impact factor: 6.261

Review 8.  Role of SNAREs in Neurodegenerative Diseases.

Authors:  Azzurra Margiotta
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

Review 9.  Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease.

Authors:  Jesús Burillo; Patricia Marqués; Beatriz Jiménez; Carlos González-Blanco; Manuel Benito; Carlos Guillén
Journal:  Cells       Date:  2021-05-18       Impact factor: 6.600

Review 10.  Functional Genomics of Axons and Synapses to Understand Neurodegenerative Diseases.

Authors:  Andres Di Paolo; Joaquin Garat; Guillermo Eastman; Joaquina Farias; Federico Dajas-Bailador; Pablo Smircich; José Roberto Sotelo-Silveira
Journal:  Front Cell Neurosci       Date:  2021-06-25       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.